Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. / Jennum, P; Riha, R L.

In: European Respiratory Journal, Vol. 33, No. 4, 01.04.2009, p. 907-14.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Jennum, P & Riha, RL 2009, 'Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing', European Respiratory Journal, vol. 33, no. 4, pp. 907-14. https://doi.org/10.1183/09031936.00180108

APA

Jennum, P., & Riha, R. L. (2009). Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. European Respiratory Journal, 33(4), 907-14. https://doi.org/10.1183/09031936.00180108

Vancouver

Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. European Respiratory Journal. 2009 Apr 1;33(4):907-14. https://doi.org/10.1183/09031936.00180108

Author

Jennum, P ; Riha, R L. / Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. In: European Respiratory Journal. 2009 ; Vol. 33, No. 4. pp. 907-14.

Bibtex

@article{0f07ecc0a6a011df928f000ea68e967b,
title = "Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing",
abstract = "Epidemiological studies have revealed a high prevalence of sleep-disordered breathing in the community (up to 20%). A subset of these patients has concurrent symptoms of excessive daytime sleepiness attributable to their nocturnal breathing disorder and is classified as having obstructive sleep apnoea/hypopnoea syndrome (4-5% of the middle-aged population). There is strong evidence for an association of sleep apnoea with cardiovascular and cerebrovascular morbidity, as well as adverse public health consequences. Treatment and diagnosis have remained largely unchanged over the past 25 yrs. In moderate-to-severe obstructive sleep apnoea/hypopnoea syndrome, treatment with continuous positive airway pressure has been shown to be effective. Questions remain as to how to screen patients with sleep-disordered breathing. Should time-consuming diagnostic procedures with high sensitivity and specificity be employed, or should simpler methods be applied for screening populations at risk, e.g. in the primary care sector?",
author = "P Jennum and Riha, {R L}",
note = "Keywords: Comorbidity; Female; Humans; Male; Risk Assessment; Risk Factors; Sleep Apnea Syndromes; Sleep Apnea, Obstructive; Syndrome",
year = "2009",
month = apr,
day = "1",
doi = "10.1183/09031936.00180108",
language = "English",
volume = "33",
pages = "907--14",
journal = "The European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "4",

}

RIS

TY - JOUR

T1 - Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing

AU - Jennum, P

AU - Riha, R L

N1 - Keywords: Comorbidity; Female; Humans; Male; Risk Assessment; Risk Factors; Sleep Apnea Syndromes; Sleep Apnea, Obstructive; Syndrome

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Epidemiological studies have revealed a high prevalence of sleep-disordered breathing in the community (up to 20%). A subset of these patients has concurrent symptoms of excessive daytime sleepiness attributable to their nocturnal breathing disorder and is classified as having obstructive sleep apnoea/hypopnoea syndrome (4-5% of the middle-aged population). There is strong evidence for an association of sleep apnoea with cardiovascular and cerebrovascular morbidity, as well as adverse public health consequences. Treatment and diagnosis have remained largely unchanged over the past 25 yrs. In moderate-to-severe obstructive sleep apnoea/hypopnoea syndrome, treatment with continuous positive airway pressure has been shown to be effective. Questions remain as to how to screen patients with sleep-disordered breathing. Should time-consuming diagnostic procedures with high sensitivity and specificity be employed, or should simpler methods be applied for screening populations at risk, e.g. in the primary care sector?

AB - Epidemiological studies have revealed a high prevalence of sleep-disordered breathing in the community (up to 20%). A subset of these patients has concurrent symptoms of excessive daytime sleepiness attributable to their nocturnal breathing disorder and is classified as having obstructive sleep apnoea/hypopnoea syndrome (4-5% of the middle-aged population). There is strong evidence for an association of sleep apnoea with cardiovascular and cerebrovascular morbidity, as well as adverse public health consequences. Treatment and diagnosis have remained largely unchanged over the past 25 yrs. In moderate-to-severe obstructive sleep apnoea/hypopnoea syndrome, treatment with continuous positive airway pressure has been shown to be effective. Questions remain as to how to screen patients with sleep-disordered breathing. Should time-consuming diagnostic procedures with high sensitivity and specificity be employed, or should simpler methods be applied for screening populations at risk, e.g. in the primary care sector?

U2 - 10.1183/09031936.00180108

DO - 10.1183/09031936.00180108

M3 - Journal article

C2 - 19336593

VL - 33

SP - 907

EP - 914

JO - The European Respiratory Journal

JF - The European Respiratory Journal

SN - 0903-1936

IS - 4

ER -

ID: 21359670